The Risk of Hypertension and Other Chronic Diseases: Comparing Smokeless Tobacco with Smoking.

Front Public Health

Department of Population Policies and Programmes, International Institute for Population Sciences, Mumbai, India.

Published: September 2017

Background: In the past, studies have compared smokeless tobacco and non-tobacco users for the risk of various chronic diseases. The differences in the risk of chronic diseases between smokeless tobacco user and smokers have not been explored. The objective of this study is to estimate the risk of chronic diseases among smokeless tobacco users compared to smokers.

Methods: The data were used from the Study on Global Ageing and Adult Health (SAGE) Wave-1, conducted in 2007-2008 in India. The study sample is the respondents who reported consuming any form of tobacco in last 1 month. The total sample size was 4,038 respondents. The odds ratio of chronic morbidities was estimated taking smokers as the reference category.

Results: The odds ratios for (self-reported) diabetes, asthma, and hypertension were not significant for smokeless tobacco user compared to smoked tobacco users. The odds ratio of chronic lung diseases (CLDs) was significantly lower among smokeless tobacco users compared to smoked tobacco users. The odds ratio of hypertension (measured) combined with low education and belonging to lowest wealth quintiles were not significant for smokeless tobacco users compared to smoked tobacco users. Duration of the use of smokeless tobacco and quantity of use was found to have no significant relation with risk of chronic diseases as compared to smoking.

Conclusion: This study did not find the significantly higher risk of chronic morbidities except for CLD for smokeless tobacco users compared to smoked tobacco users. The study suggests that the use of any form of tobacco may have a similar risk of chronic diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614917PMC
http://dx.doi.org/10.3389/fpubh.2017.00255DOI Listing

Publication Analysis

Top Keywords

smokeless tobacco
36
tobacco users
32
chronic diseases
24
risk chronic
24
users compared
16
compared smoked
16
smoked tobacco
16
tobacco
15
odds ratio
12
chronic
9

Similar Publications

Chronic exposure to arsenic can lead to various health issues, including cancer. Concerns have been mounting about the enhancement of arsenic toxicity through co-exposure to various prevalent lifestyle habits. Smokeless tobacco (SLT) products are commonly consumed in South Asian countries, where their use frequently co-occurs with exposure to arsenic from contaminated groundwater.

View Article and Find Full Text PDF

Background: Smokeless tobacco (SLT) use is a major public health problem in many parts of the world, including India. Despite this, smokeless tobacco often doesn't receive enough attention. The aim of this study was to assess the pH, moisture, nicotine levels, and warning labels on smokeless tobacco products sold in Pondicherry, India.

View Article and Find Full Text PDF

Public Awareness and Knowledge of Oral Cancer in 13 Middle Eastern and North African Countries.

JAMA Netw Open

March 2025

Department of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.

Importance: Public awareness of oral cancer is crucial for prevention, early detection, and improved survival rates. Knowledge gaps in Middle Eastern and North African countries and areas for public education need to be assessed.

Objective: To evaluate public knowledge and awareness of oral cancer, including risk factors, signs and symptoms, and protective measures, in Middle Eastern and North African countries.

View Article and Find Full Text PDF

Background/aim: Tobacco addiction is prevalent in South and Southeast Asia. This study aimed to assess upper gastrointestinal (GI) tract changes in smokeless tobacco (SLT) users through upper GI endoscopy (UGIE).

Materials And Methods: A cross-sectional observational study, including 108 SLT users and 90 controls who did not use tobacco, was conducted at an Indian tertiary care hospital from March 2022 to February 2023.

View Article and Find Full Text PDF

Use of flavored and modified risk smokeless tobacco products among American Indian adults.

Nicotine Tob Res

February 2025

Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, 801 NE 13th Street, CHB 309A, Oklahoma City, OK 73126, United States.

Introduction: Little is known about the use of modified risk smokeless tobacco products (MRSTP) and flavored smokeless tobacco (ST) products among American Indians (AI). Aim of this study is to evaluate differences in tobacco use characteristics, ST dependence, and cotinine levels according to the use of flavored ST and MRSTP among AI ST users.

Methods: Study was based on cross-sectional data collected from a community-based sample of 120 adult male AI exclusive ST users.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!